Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Introduction: Results of previous clinical trials evaluating the effect of resveratrol supplementation on blood pressure (BP) are controversial.Purpose: We aimed to assess the impact of resveratrol on BP through systematic review of literature and meta-analysis of available randomized, controlled clinical trials (RCTs).Methods: Literature search included SCOPUS, PubMed-Medline, ISI Web of Science and Google Scholar databases up to 17th October 2017 to identify RCTs investigating the impact of resveratrol on BP. Two review authors independently extracted data on study characteristics, methods and outcomes. Overall, the impact of resveratrol on BP was reported in 17 trials.Results: Administration of resveratrol did not significantly affect neither systolic BP [weighted mean difference (WMD): −2.5 95% CI:(-5.5, 0.6) mmHg; p=0.116; I2=62.1%], nor diastolic BP [WMD: −0.5 95% CI:(-2.2, 1.3) mmHg; p=0.613; I2=50.8], nor mean BP [MAP; WMD: −1.3 95% CI:(-2.8, 0.1) mmHg; p=0.070; I2=39.5%] nor pulse pressure [PP; WMD: −0.9 95% CI:(-3.1, 1.4) mmHg; p=0.449; I2=19.2%]. However, significant WMDs were detected in subsets of studies categorized according to high resveratrol daily dosage (≥300 mg/day) and presence of diabetes. Meta-regression analysis revealed a positive association between systolic BP-lowering resveratrol activity (slope: 1.99; 95% CI: 0.05, 3.93; two-tailed p= 0.04) and Body Mass Index (BMI) at baseline, while no association was detected neither between baseline BMI and MAP-lowering resveratrol activity (slope: 1.35; 95% CI: −0.22, 2.91; two-tailed p= 0.09) nor between baseline BMI and PP-lowering resveratrol activity (slope: 1.03; 95% CI: −1.33, 3.39; two-tailed p= 0.39). Resveratrol was fairly well-tolerated and no serious adverse events occurred among most of the eligible trials.Conclusion: The favourable effect of resveratrol emerging from the current meta-analysis suggests the possible use of this nutraceutical as active compound in order to promote cardiovascular health, mostly when used in high daily dose (≥300 mg/day) and in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · cited 5×
“…2016; Chen et al. 2015; Faghihzadeh et al. 2015; van der Made et al. 2015; Anton et al. 2014; Chachay et al. 2014; M endez-del Villar et al. 2014; Kumar and Joghee 2013; Tom e-Carneiro et al. 2013; Movahde et al. 2013; Wong et al. 2013; Bhatt et al. 2012; Yoshino et al. 2012; Timmers et al. 2011).”
BackgroundInfluentialBioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475 · cited 3×
“(Kjær et al. 2017; Imamura et al. 2017; Heebøll et al. 2016; Chen et al. 2015; Faghihzadeh et al. 2015; Anton et al. 2014; Chachay et al. 2014; M endez-del Villar et al. 2014; Kumar and Joghee 2013; Tom e-Carneiro et al. 2013; Movahde et al. 2013; Bhatt et al. 2012; Yoshino et al. 2012) .”
BackgroundChen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., Shu, F., Gao, Y., Yuan, L., Zhang, Q., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.015 · Cited by 319 · cited 5×
“(Kjær et al. 2017; Imamura et al. 2017; Heebøll et al. 2016; Timmers et al. 2016; Chen et al. 2015; Faghihzadeh et al. 2015; van der Made et al. 2015; Anton et al. 2014; Chachay et al. 2014; M endez-del Villar et al. 2014; Kumar and Joghee 2013; Tom e-Carneiro et al. 2013; Movahde et al. 2013; Wong…”
BackgroundInfluentialSerban, M., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., Andrica, F., Ahmed, A., Aronow, W. S., Muntner, P., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002713 · Cited by 317
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281 · cited 3×
“…of hypertension, through a multitude of mechanisms mostly including its antioxidant properties, the stimulation of endothelial nitride oxide production, the inhibition of vascular inflammation and the prevention of platelet aggregation (Borghi and Cicero 2017; Cicero et al. 2017; Li et al. 2012).”
BackgroundSelf-citationMéndez-del Villar, M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0082 · Cited by 246 · cited 3×
“…2015; Anton et al. 2014; Wong et al. 2013; Yoshino et al. 2012; Timmers et al. 2011). or individuals affected by MetS, (Kjær et al. 2017; M endez-del Villar et al. 2014). well controlled T2DM, [Imamura et al. 2017; Timmers et al. 2016; Kumar and Joghee 2013; Movahde et al. 2013; Bhatt et al.…”
BackgroundPrimary Prevention of Cardiovascular Disease in Diabetes Mellitus
Newman, J. D., Schwartzbard, A. Z., Weintraub, H. S., Goldberg, I. J., & Berger, J. S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.001 · Cited by 205
Zhu, X., Wu, C., Qiu, S., Yuan, X., & Li, L. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0217-z · Cited by 196 · cited 1×
“Moreover, the insulin-sensitivity improving effect of resveratrol, that contribute to its blood pressure improving effect, could also have a positive impact on diabetes control (Zhu et al. 2017).”
Background
Research works printed but not linked: 30
- 10.1007/s40292-017-0236-x · DOI
- 10.1016/j.jconrel.2011.09.083 · DOI · Paper page
- Borenstein M., 2005, Biostatistics, 2005, 104
- 10.1111/bcp.12902 · DOI · Paper page
- 10.1016/j.phrs.2017.08.015 · DOI
- 10.1016/j.cgh.2014.02.024 · DOI · Paper page
- 10.1039/C7FO00178A · DOI · Paper page
- 10.1007/s40292-015-0081-8 · DOI
- 10.1111/j.0006-341X.2000.00455.x · DOI · Paper page
- Fogacci F., 2017, Critical Reviews in Food Science and Nutrition, 30, 0
- 10.1016/0895-4356(92)90054-Q · DOI · Paper page
- Higgins J., 2010, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0. 2. 2009
- 10.1536/ihj.16-373 · DOI · Paper page
- 10.7897/2230-8407.04849 · DOI
- 10.1210/jc.2016-2160 · DOI · Paper page
- 10.1016/j.niox.2011.12.006 · DOI · Paper page
- 10.1016/j.clnu.2014.03.009 · DOI · Paper page
- 10.1136/bmj.b2535 · DOI · Paper page
- 10.1155/2013/851267 · DOI · Paper page
- 10.1210/jc.2014-2799 · DOI · Paper page
- 10.1007/s11906-017-0785-3 · DOI
- 10.1016/j.metabol.2016.08.007 · DOI
- 10.1016/j.ijcard.2015.04.008 · DOI · Paper page
- 10.3892/etm.2015.2895 · DOI · Paper page
- 10.3109/07853890.2015.1078905 · DOI
- 10.21037/cdt.2017.03.20 · DOI · Paper page
- 10.1007/s10557-012-6427-8 · DOI · Paper page
- 10.2337/dc16-0499 · DOI · Paper page
- 10.1124/dmd.104.000885 · DOI · Paper page
- 10.1016/j.cmet.2012.09.015 · DOI · Paper page
Cited by
Resveratrol and Its Effects on the Vascular System
Breuss, J. M., Atanasov, A. G., & Uhrin, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071523 · Cited by 328
Resveratrol, Metabolic Syndrome, and Gut Microbiota
Chaplin, A., Carpéné, C., & Mercader, J. (2018) · Nutrients · doi:10.3390/nu10111651 · Cited by 242
“According to these analyses, a beneficial effect of resveratrol supplementation on blood pressure is observed when the effect is analyzed among diabetic patients [89] or overweight and obese individuals [88].”
BackgroundMicronutrient Supplementation to Reduce Cardiovascular Risk
An, P., Wan, S., Luo, Y., Luo, J., Zhang, X., Zhou, S., Xu, T., He, J., Mechanick, J. I., Wu, W.-C., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.048 · Cited by 189
Grosso, G., Godos, J., Currenti, W., Micek, A., Falzone, L., Libra, M., Giampieri, F., Forbes-Hernández, T. Y., Quiles, J. L., Battino, M., et al. (2022) · Nutrients · doi:10.3390/nu14030545 · Cited by 165
“Some studies investigating polyphenol supplementation consistently revealed null effects on blood pressure, suggesting that the lack of significant results may be due to the limited number of included studies and their quality; among the existing meta-analyses, supplementation ith hesperidin (a major flavanone contain…”
ResultCicero, A. F. G., Grassi, D., Tocci, G., Galletti, F., Borghi, C., & Ferri, C. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0296-6 · Cited by 79
Self-citation
Metadata
- Authors
- Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G.
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2018-01-23
- Volume
- 59
- Issue
- 10
- Pages
- 1605-1618
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W2791625216
- Cited by
- 141
- References
- 16
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. https://app.cochat.ai/papers/10.1080/10408398.2017.1422480
- The paper
- Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G. (2019). Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2017.1422480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.